Dashboard
Manage Tickers

AUTLAutolus Therapeutics plc

Nasdaq autolus.com


$ 4.10 $ -0.03 (-0.73 %)    

Wednesday, 11-Sep-2024 15:59:58 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 468.28 $ 9.96 (2.17 %)
DIA $ 409.73 $ 1.01 (0.25 %)
SPY $ 554.79 $ 5.63 (1.03 %)
TLT $ 100.61 $ -0.08 (-0.08 %)
GLD $ 232.25 $ -0.37 (-0.16 %)
$ 4.09
$ 4.09 x 600
-- x --
-- - --
$ 2.01 - $ 7.45
605,027
na
1.09B
$ 1.87
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-08-2024 06-30-2024 10-Q
2 05-17-2024 03-31-2024 10-Q
3 03-21-2024 12-31-2023 10-K
4 11-09-2023 09-30-2023 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

autolus-therapeutics-to-present-tumor-burden-guided-dosing-data-at-soho-2024
Autolus Therapeutics to Present Tumor Burd...
08/27/2024 11:02:02

Autolus Therapeutics plc (NASDAQ:AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell...

autolus-therapeutics-q2-eps-022-misses-019-estimate-company-exits-quarter-with-cash--equivalents-worth-7059m
Autolus Therapeutics Q2 EPS $(0.22) Misses...
08/08/2024 11:07:25

Autolus Therapeutics (NASDAQ:AUTL) reported quarterly losses of $(0.22) per share which missed the analyst consensus estimate o...

a-glimpse-into-the-expert-outlook-on-autolus-therapeutics-through-5-analysts
A Glimpse Into The Expert Outlook On Autol...
06/17/2024 13:00:30

needham-reiterates-buy-on-autolus-therapeutics-maintains-9-price-target
Needham Reiterates Buy on Autolus Therapeu...
06/17/2024 09:52:54

Needham analyst Gil Blum reiterates Autolus Therapeutics (NASDAQ:AUTL) with a Buy and maintains $9 price target.

autolus-therapeutics-says-it-will-reveal-three-abstracts-to-be-presented-at-european-hematology-association-eha-congress
Autolus Therapeutics Says It Will Reveal T...
06/14/2024 11:14:29

needham-reiterates-buy-on-autolus-therapeutics-maintains-9-price-target
Needham Reiterates Buy on Autolus Therapeu...
06/03/2024 10:07:43

Needham analyst Gil Blum reiterates Autolus Therapeutics (NASDAQ:AUTL) with a Buy and maintains $9 price target.

autolus-therapeutics-presents-additional-data-analysis-of-pivotal-phase-2-felix-study-of-obe-cel-for-adult-rr-b-all-in-an-oral-presentation-at-asco
Autolus Therapeutics Presents Additional D...
05/31/2024 12:11:45

The majority of patients that responded to obe-cel showed durable responses with the potential for a long-term plateau of survi...

crude-oil-gains-1-gamestop-shares-plunge
Crude Oil Gains 1%; GameStop Shares Plunge
05/17/2024 18:48:26

why-cracker-barrel-shares-are-trading-lower-by-around-14-here-are-other-stocks-moving-in-fridays-mid-day-session
Why Cracker Barrel Shares Are Trading Lowe...
05/17/2024 18:18:06

needham-reiterates-buy-on-autolus-therapeutics-maintains-9-price-target
Needham Reiterates Buy on Autolus Therapeu...
05/17/2024 17:42:30

Needham analyst Gil Blum reiterates Autolus Therapeutics (NASDAQ:AUTL) with a Buy and maintains $9 price target.

despegarcom-posts-strong-sales-joins-reddit-robinhood-and-other-big-stocks-moving-higher-on-friday
Despegar.com Posts Strong Sales, Joins Red...
05/17/2024 14:11:14

autolus-therapeutics-q1-eps-024-compared-with-023-yoy-quarterly-sales-totals-1009m-exits-quarter-with-cash--equivalents-worth-7585m
Autolus Therapeutics Q1 EPS $(0.24) Compar...
05/17/2024 11:10:04

Autolus Therapeutics (NASDAQ:AUTL) reported quarterly losses of $(0.24)

autolus-therapeutics-presents-3-clinical-data-updates-on-obe-cel-in-relapsedrefractory-b-cell-acute-lymphoblastic-leukemia-patients-at-the-2024-eha-congress-june-13-16-2024
Autolus Therapeutics Presents 3 Clinical D...
05/14/2024 14:05:28

Autolus Therapeutics plc (NASDAQ:AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell...

autolus-therapeutics-delays-its-first-quarter-2024-earnings-release-and-conference-call
Autolus Therapeutics Delays Its First Quar...
05/13/2024 11:27:26

The Company is canceling its previously announced earnings release and call scheduled for before U.S. market open on May 14, 20...

autolus-therapeutics-announces-abstract-for-longer-term-follow-up-and-additional-data-analysis-of-pivotal-phase-2-felix-study-of-obe-cel-for-adult-rr-b-all-selected-for-an-oral-presentation-at-asco
Autolus Therapeutics Announces Abstract Fo...
04/24/2024 14:04:16

Autolus Therapeutics plc (NASDAQ:AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell...

needham-reiterates-buy-on-autolus-therapeutics-maintains-9-price-target
Needham Reiterates Buy on Autolus Therapeu...
04/12/2024 10:01:53

Needham analyst Gil Blum reiterates Autolus Therapeutics (NASDAQ:AUTL) with a Buy and maintains $9 price target.

12-health-care-stocks-moving-in-thursdays-after-market-session
12 Health Care Stocks Moving In Thursday's...
04/11/2024 20:31:16

truist-securities-maintains-buy-on-autolus-therapeutics-raises-price-target-to-11
Truist Securities Maintains Buy on Autolus...
04/09/2024 17:41:03

Truist Securities analyst Gil Blum maintains Autolus Therapeutics (NASDAQ:AUTL) with a Buy and raises the price target from ...

autolus-therapeutics-announced-acceptance-of-marketing-authorization-application-by-european-medicines-agency-for-obecabtagene-autoleucel-for-patients-with-relapsedrefractory-adult-b-cell-acute-lymphoblastic-leukemia
Autolus Therapeutics Announced Acceptance ...
04/02/2024 11:07:56

autolus-therapeutics-plc-files-for-resale-of-up-to-3333m-shares-by-the-selling-securityholder
Autolus Therapeutics Plc Files For Resale ...
03/28/2024 20:22:41

S-3ASR

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION